Frontline Ventures

Frontline Ventures is a transatlantic venture capital firm with offices in Dublin, London, and New York, focused on early-stage business-to-business software companies. The firm was built around a specific insight: ambitious European software founders often need a partner that genuinely understands the United States as a market, not just as a logo on a slide. Frontline structures itself accordingly, with separate vehicles for European seed investing and for helping US companies expand into Europe.

The healthcare thesis sits inside the broader B2B software focus and centers on healthcare software and digital health products that sell to enterprise buyers. That includes clinical operations software, payor and provider tools, life sciences software, AI applications targeted at healthcare enterprises, revenue cycle and back-office automation, and infrastructure software with healthcare as a major vertical. The firm is less active in pure consumer health, regulated medical devices, or therapeutics, where the B2B SaaS pattern does not apply.

Investments are typically Pre-Seed and Seed with checks in the one to five million dollar range. Geographic focus reflects the firm’s transatlantic structure: European seed investments concentrate in Ireland, the United Kingdom, and continental Europe, while the growth fund supports US companies entering Europe. The seed fund leads or co-leads at the early stages and uses its US network actively to support portfolio companies’ expansion.

The partnership has been stable over multiple funds and is built around investing partners with operator and venture backgrounds across both sides of the Atlantic. Founders should expect engagement focused on go-to-market, particularly the realities of selling enterprise software across multiple geographies, which the firm has more pattern recognition on than most European seed funds.

The practical value of Frontline is the transatlantic playbook. Portfolio companies get help on the specific operational questions European founders face when they target US customers, including hiring a US team, structuring entities, sequencing East Coast versus West Coast presence, and managing the time-zone realities of running a transatlantic team. The firm’s network on both sides is genuinely useful for warm customer and follow-on investor introductions. The fit is strongest for ambitious European B2B SaaS founders, including healthcare software companies, whose addressable market clearly includes the United States and who want a partner that has helped many similar companies make the jump. The fit is weaker for companies with a purely European focus or for healthcare companies whose model does not fit a B2B software shape, where a more sector-specialized investor is usually a closer match.